Volume | 3,346 |
|
|||||
News | - | ||||||
Day High | 143.97 | Low High |
|||||
Day Low | 142.61 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
First Trust NYSE Arca Biotechnology Index Fund | FBT | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
142.95 | 142.61 | 143.97 | 142.59 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
77 | 3,346 | 143.43 | 479,926 | - | 130.2701 - 161.41 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
11:09:56 | 1 | 143.91 | USD |
First Trust NYSE Arca Biotechnology Index Fund Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.17B | 8.15M | - | 3.48M | 20.93M | 2.57 | 55.94 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News First Trust NYSE Arca Bi...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FBT Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 141.26 | 146.59 | 140.36 | 143.22 | 24,726 | 2.71 | 1.92% |
1 Month | 153.50 | 154.25 | 140.36 | 147.52 | 24,939 | -9.53 | -6.21% |
3 Months | 149.07 | 156.99 | 140.36 | 150.17 | 27,195 | -5.10 | -3.42% |
6 Months | 135.17 | 161.41 | 130.2701 | 148.12 | 30,765 | 8.80 | 6.51% |
1 Year | 152.50 | 161.41 | 130.2701 | 150.13 | 30,254 | -8.53 | -5.59% |
3 Years | 164.84 | 176.64 | 121.6785 | 152.08 | 38,748 | -20.87 | -12.66% |
5 Years | 138.99 | 186.5106 | 108.08 | 147.43 | 69,201 | 4.98 | 3.58% |
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. |